Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).

While biologic treatments do not cure rheumatoid arthritis (RA), they can slow its progression. They may also cause fewer side effects than other kinds of medications. Biological response ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

RA progression involves distinct stages, each bringing different changes to the body. Some are visible and felt, while others ...

Patients with early RA who did not require a biologic disease-modifying antirheumatic drug (DMARD) had a higher chance of ...

Genetic markers may help predict response to TNF inhibitor therapy in rheumatoid arthritis, potentially leading to more ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes swelling, pain, and stiffness in the joints. Scientists from ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), ...